Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s diseaseViviane Tabar, Claire Henchcliffe, Suneil K. Kalia et al.|Nature|2025Cited by 131
Safety, Tolerability, and Clinical Assessment of Bemdaneprocel for Parkinson’s Disease: 18-month Results from a Phase 1 Study (P9-3.007)Claire Henchcliffe, Viviane Tabar, Harini Sarva et al.|Neurology|2024Cited by 0